A 24-week, prospective, randomized, open-label, treat-to-target pilot study of obese type 2 diabetes patients with severe insulin resistance to assess the addition of exenatide on the efficacy of u-500 regular insulin plus metformin.

Distiller, Larry A; Nortje, Hendrik; Wellmann, Holger; Amod, Aslam; Lombard, Landman

Distiller, Larry A; Nortje, Hendrik; Wellmann, Holger; Amod, Aslam; Lombard, Landman.

Afiliação

Distiller LA; Centre for Diabetes and Endocrinology, Johannesburg, South Africa.
Nortje H; N1 City Medical Chambers, Goodwood, Cape Town, South Africa.
Wellmann H; Helderberg Clinical Trials Centre, Somerset West, South Africa.
Amod A; Life Chatsmed Garden Hospital and Nelson R Mandela School of Medicine, Durban, South Africa.
Lombard L; Kuils River Netcare Hospital, Cape Town, South Africa.

Endocr Pract ; 20(11): 1143-50, 2014 Nov.

Article em En | MEDLINE | ID: mdl-24936555

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article